Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons

Molecular Biology of the Cell

Volumn 19, Issue 12, 2008, Pages 5226-5237

  Dong, Min ^a   Liu, Huisheng ^a   Tepp, William H ^a   Johnson, Eric A ^a   Janz, Roger ^b   Chapman, Edwin R ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN E; GANGLIOSIDE; GLYCOSYLATED PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; SYNAPTIC VESICLE 2 PROTEIN; SYNAPTIC VESICLE 2A PROTEIN; SYNAPTIC VESICLE 2B PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; EXPERIMENTAL MOUSE; GLYCOSYLATION; MOUSE; MUTANT; NERVE CELL; NERVE CELL MEMBRANE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RAT; SYNAPSE VESICLE;

AMINO ACID SEQUENCE; ANIMALS; BOTULINUM TOXINS; CELLS, CULTURED; GANGLIOSIDES; GLYCOSYLATION; HIPPOCAMPUS; HUMANS; MEMBRANE GLYCOPROTEINS; MEMBRANE POTENTIALS; MICE; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS; NEURONS; PROTEIN ISOFORMS; RATS; RECOMBINANT FUSION PROTEINS; SEQUENCE ALIGNMENT; SYNAPTIC VESICLES; VIRUS INTERNALIZATION;

ANIMALIA; MUS;

EID: 58549094719     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E08-07-0765     Document Type: Article

References (60)

1. Aoki, K. R. (2004). Botulinum toxin: a successful therapeutic protein. Curr. Med. Chem. 11, 3085-3092.
2. Arnon, S. S. et al. (2001). Botulinum toxin as a biological weapon: medical and public health management. J. Am. Med. Assoc. 285, 1059-1070.
3. Bajjalieh, S. M., Frantz, G. D., Weimann, J. M., McConnell, S. K., and Scheller, R. H. (1994). Differential expression of synaptic vesicle protein 2 (SV2) isoforms. J. Neurosci. 14, 5223-5235.
4. Bajjalieh, S. M., Peterson, K., Linial, M., and Scheller, R. H. (1993). Brain contains two forms of synaptic vesicle protein 2. Proc. Natl. Acad. Sci. USA 90, 2150-2154.
5. Bajjalieh, S. M., Peterson, K., Shinghal, R., and Scheller, R. H. (1992). SV2, a brain synaptic vesicle protein homologous to bacterial transporters. Science 257, 1271-1273.
6. Baldwin, M. R., and Barbieri, J. T. (2007). Association of botulinum neurotoxin serotypes a and B with synaptic vesicle protein complexes. Biochemistry 46, 3200-3210.
7. Blasi, J., Chapman, E. R., Link, E., Binz, T., Yamasaki, S., De Camilli, P., Sudhof, T. C., Niemann, H., and Jahn, R. (1993a). Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25. Nature 365, 160-163.
8. Blasi, J., Chapman, E. R., Yamasaki, S., Binz, T., Niemann, H., and Jahn, R. (1993b). Botulinum neurotoxin C1 blocks neurotransmitter release by means of cleaving HPC-1/syntaxin. EMBO J. 12, 4821-4828.
9. Buckley, K., and Kelly, R. B. (1985). Identification of a transmembrane glycoprotein specific for secretory vesicles of neural and endocrine cells. J. Cell Biol. 100, 1284-1294.
10. Bullens, R. W., O'Hanlon, G. M., Wagner, E., Molenaar, P. C., Furukawa, K., Plomp, J. J., and Willison, H. J. (2002). Complex gangliosides at the neuromuscular junction are membrane receptors for autoantibodies and botulinum neurotoxin but redundant for normal synaptic function. J. Neurosci. 22, 6876-6884.
11. Chai, Q., Arndt, J. W., Dong, M., Tepp, W. H., Johnson, E. A., Chapman, E. R., and Stevens, R. C. (2006). Structural basis of cell surface receptor recognition by botulinum neurotoxin B. Nature 444, 1096-1100.
12. Chapman, E. R., and Jahn, R. (1994). Calcium-dependent interaction of the cytoplasmic region of synaptotagmin with membranes. Autonomous function of a single C2-homologous domain. J. Biol. Chem. 269, 5735-5741.
13. Crowder, K. M., Gunther, J. M., Jones, T. A., Hale, B. D., Zhang, H. Z., Peterson, M. R., Scheller, R. H., Chavkin, C., and Bajjalieh, S. M. (1999). Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A). Proc. Natl. Acad. Sci. USA 96, 15268-15273.
14. Dodick, D., Blumenfeld, A., and Silberstein, S. D. (2004). Botulinum neurotoxin for the treatment of migraine and other primary headache disorders. Clin. Dermatol. 22, 76-81.
15. Dolly, J. O., Black, J., Williams, R. S., and Melling, J. (1984). Acceptors for botulinum neurotoxin reside on motor nerve terminals and mediate its internalization. Nature 307, 457-460.
16. Dong, M., Richards, D. A., Goodnough, M. C., Tepp, W. H., Johnson, E. A., and Chapman, E. R. (2003). Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells. J. Cell Biol. 162, 1293-1303.
17. Dong, M., Tepp, W. H., Liu, H., Johnson, E. A., and Chapman, E. R. (2007). Mechanism of botulinum neurotoxin B and G entry into hippocampal neurons. J. Cell Biol. 179, 1511-1522.
18. Dong, M., Yeh, F., Tepp, W. H., Dean, C., Johnson, E. A., Janz, R., and Chapman, E. R. (2006). SV2 is the protein receptor for botulinum neurotoxin A. Science 312, 592-596.
19. Feany, M. B., Lee, S., Edwards, R. H., and Buckley, K. M. (1992). The synaptic vesicle protein SV2 is a novel type of transmembrane transporter. Cell 70, 861-867.
20. Fischer, A., and Montal, M. (2007). Single molecule detection of intermediates during botulinum neurotoxin translocation across membranes. Proc. Natl. Acad. Sci. USA 104, 10447-10452.
21. Gascon, S., Paez-Gomez, J. A., Diaz-Guerra, M., Scheiffele, P., and Scholl, F. G. (2008). Dual-promoter lentiviral vectors for constitutive and regulated gene expression in neurons. J. Neurosci. Methods 168, 104-112.
22. 2+ sensor for transmitter release at a central synapse. Cell 79, 717-727.
23. Hoch, D. H., Romero-Mira, M., Ehrlich, B. E., Finkelstein, A., DasGupta, B. R., and Simpson, L. L. (1985). Channels formed by botulinum, tetanus, and diphtheria toxins in planar lipid bilayers: relevance to translocation of proteins across membranes. Proc. Natl. Acad. Sci. USA 82, 1692-1696.
24. Jahn, R., and Scheller, R. H. (2006). SNAREs - engines for membrane fusion. Nat. Rev. Mol. Cell Biol. 7, 631-643.
25. Jahn, R., and Sudhof, T. C. (1999). Membrane fusion and exocytosis. Annu. Rev. Biochem. 68, 863-911.
26. 2+ regulators in neurotransmitter release. Neuron 24, 1003-1016.
27. Janz, R., and Sudhof, T. C. (1999). SV2C is a synaptic vesicle protein with an unusually restricted localization: anatomy of a synaptic vesicle protein family. Neuroscience 94, 1279-1290.
28. Jin, R., Rummel, A., Binz, T., and Brunger, A. T. (2006). Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity. Nature 444, 1092-1095.
29. Johnson, E. A. (1999). Clostridial toxins as therapeutic agents: benefits of nature's most toxic proteins. Annu. Rev. Microbiol. 53, 551-575.
30. Kamata, Y., Kozaki, S., Sakaguchi, G., Iwamori, M., and Nagai, Y. (1986). Evidence for direct binding of Clostridium botulinum type E derivative toxin and its fragments to gangliosides and free fatty acids. Biochemical and biophysical research communications 140, 1015-1019.
31. Keller, J. E., Cai, F., and Neale, E. A. (2004). Uptake of botulinum neurotoxin into cultured neurons. Biochemistry 43, 526-532.
32. Kitamura, M., Iwamori, M., and Nagai, Y. (1980). Interaction between Clostridium botulinum neurotoxin and gangliosides. Biochim. Biophys. Acta 628, 328-335.
33. Kitamura, M., Takamiya, K., Aizawa, S., and Furukawa, K. (1999). Gangliosides are the binding substances in neural cells for tetanus and botulinum toxins in mice. Biochim. Biophys. Acta 1441, 1-3.
34. Koriazova, L. K., and Montal, M. (2003). Translocation of botulinum neurotoxin light chain protease through the heavy chain channel. Nat. Struct. Biol. 10, 13-18.
35. Kozaki, S., Kamata, Y., Watarai, S., Nishiki, T., and Mochida, S. (1998). Ganglioside GT1b as a complementary receptor component for Clostridium botulinum neurotoxins. Microb. Pathog. 25, 91-99.
36. Lawrence, G., Wang, J., Chion, C. K., Aoki, K. R., and Dolly, J. O. (2007). Two protein trafficking processes at motor nerve endings unveiled by botulinum neurotoxin E. J. Pharmacol. Exp. Therapeut. 320, 410-418.
37. Liu, Y. et al. (1999). A genetic model of substrate deprivation therapy for a glycosphingolipid storage disorder. J. Clin. Invest. 103, 497-505.
38. Mahrhold, S., Rummel, A., Bigalke, H., Davletov, B., and Binz, T. (2006). The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves. FEBS Lett. 580, 2011-2014.
39. Miesenbock, G., and Rothman, J. E. (1997). Patterns of synaptic activity in neural networks recorded by light emission from synaptolucins. Proc. Natl. Acad. Sci. USA 94, 3402-3407.
40. Montecucco, C. (1986). How do tetanus and botulinum toxins bind to neuronal membranes? Trends Biochem. Sci. 314-317.
41. Nishiki, T., Kamata, Y., Nemoto, Y., Omori, A., Ito, T., Takahashi, M., and Kozaki, S. (1994). Identification of protein receptor for Clostridium botulinum type B neurotoxin in rat brain synaptosomes. J. Biol. Chem. 269, 10498-10503.
42. Nishiki, T., Tokuyama, Y., Kamata, Y., Nemoto, Y., Yoshida, A., Sato, K., Sekiguchi, M., Takahashi, M., and Kozaki, S. (1996). The high-affinity binding of Clostridium botulinum type B neurotoxin to synaptotagmin II associated with gangliosides GT1b/GD1a. FEBS Lett. 378, 253-257.
43. Rothman, J. E., and Warren, G. (1994). Implications of the SNARE hypothesis for intracellular membrane topology and dynamics. Curr. Biol. 4, 220-233.
44. Rummel, A. et al. (2007). Identification of the protein receptor binding site of botulinum neurotoxins B and G proves the double-receptor concept. Proc. Natl. Acad. Sci. USA 104, 359-364.
45. Rummel, A., Karnath, T., Henke, T., Bigalke, H., and Binz, T. (2004a). Synaptotagmins I and II act as nerve cell receptors for botulinum neurotoxin G. J. Biol. Chem. 279, 30865-30870.
46. Rummel, A., Mahrhold, S., Bigalke, H., and Binz, T. (2004b). The HCC-domain of botulinum neurotoxins A and B exhibits a singular ganglioside binding site displaying serotype specific carbohydrate interaction. Mol. Microbiol. 51, 631-643.
47. Schiavo, G., Benfenati, F., Poulain, B., Rossetto, O., Polverino de Laureto, P., DasGupta, B. R., and Montecucco, C. (1992). Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature 359, 832-835.
48. Schiavo, G., Malizio, C., Trimble, W. S., Polverino de Laureto, P., Milan, G., Sugiyama, H., Johnson, E. A., and Montecucco, C. (1994). Botulinum G neurotoxin cleaves VAMP/synaptobrevin at a single Ala-Ala peptide bond. J. Biol. Chem. 269, 20213-20216.
49. Schiavo, G., Matteoli, M., and Montecucco, C. (2000). Neurotoxins affecting neuroexocytosis. Physiol. Rev. 80, 717-766.
50. Schiavo, G., Rossetto, O., Catsicas, S., Polverino de Laureto, P., DasGupta, B. R., Benfenati, F., and Montecucco, C. (1993a). Identification of the nerve terminal targets of botulinum neurotoxin serotypes A, D, and E. J. Biol. Chem. 268, 23784-23787.
51. Schiavo, G., Shone, C. C., Rossetto, O., Alexander, F. C., and Montecucco, C. (1993b). Botulinum neurotoxin serotype F is a zinc endopeptidase specific for VAMP/synaptobrevin. The J. Biol. Chem. 268, 11516-11519.
52. Scranton, T. W., Iwata, M., and Carlson, S. S. (1993). The SV2 protein of synaptic vesicles is a keratan sulfate proteoglycan. J. Neurochem. 61, 29-44.
53. Simpson, L. L. (2004). Identification of the major steps in botulinum toxin action. Annu. Rev. Pharmacol. Toxicol. 44, 167-193.
54. Sobel, J. (2005). Botulism. Clin. Infect. Dis. 41, 1167-1173.
55. Tsukamoto, K., Kohda, T., Mukamoto, M., Takeuchi, K., Ihara, H., Saito, M., and Kozaki, S. (2005). Binding of Clostridium botulinum type C and D neurotoxins to ganglioside and phospholipid. Novel insights into the receptor for clostridial neurotoxins. J. Biol. Chem. 280, 35164-35171.
56. Verderio, C., Grumelli, C., Raiteri, L., Coco, S., Paluzzi, S., Caccin, P., Rossetto, O., Bonanno, G., Montecucco, C., and Matteoli, M. (2007). Traffic of botulinum toxins A and E in excitatory and inhibitory neurons. Traffic 8, 142-153.
57. Yowler, B. C., Kensinger, R. D., and Schengrund, C. L. (2002). Botulinum neurotoxin A activity is dependent upon the presence of specific gangliosides in neuroblastoma cells expressing synaptotagmin I. J. Biol. Chem. 277, 32815-32819.
58. Yowler, B. C., and Schengrund, C. L. (2004). Botulinum neurotoxin A changes conformation upon binding to ganglioside GT1b. Biochemistry 43, 9725-9731.
59. Yule, A. M., Austin, J. W., Barker, I. K., Cadieux, B., and Moccia, R. D. (2006). Persistence of Clostridium botulinum neurotoxin type E in tissues from selected freshwater fish species: implications to public health. J. Food Protect. 69, 1164-1167.
60. Zhou, L., Zhang, C. L., Messing, A., and Chiu, S. Y. (1998). Temperature-sensitive neuromuscular transmission in Kv1.1 null mice: role of potassium channels under the myelin sheath in young nerves. J. Neurosci. 18, 7200-7215.